Drug Resistance Updates

SJR Rank #264H-index: 148SJR: 5.279Best quartile: Q1APC: US$5,410
Journal website: aims, scope and author guidelines
Publisher

Churchill Livingstone

Country

United Kingdom

Type

journal

SJR by Edition

2022202502468

Subject Categories

  • Cancer ResearchQ1
  • Infectious DiseasesQ1
  • OncologyQ1
  • PharmacologyQ1
  • Pharmacology (medical)Q1

Areas: Biochemistry, Genetics and Molecular Biology · Medicine · Pharmacology, Toxicology and Pharmaceutics

Most published research topics

Human auditory perception and evaluationEducational Robotics and EngineeringDiverse Scientific and Economic StudiesAntibiotic Resistance in BacteriaDrug Transport and Resistance MechanismsCancer, Hypoxia, and MetabolismHIV/AIDS drug development and treatmentCancer therapeutics and mechanismsCancer-related Molecular PathwaysCell death mechanisms and regulation

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs055110165220

Documents per Year

202220250255075100

Detailed Information

ISSN

1368-7646, 1532-2084

SJR Best Quartile

Q1

Region

Western Europe

Citations per Document (2 years)

21.95

References per Document

110.32

Coverage

1998-2026

Scope

Drug Resistance Updates is a bimonthly publication that contains thought-provoking reviews on important developments in drug resistance in infectious disease and cancer as well as novel drugs and strategies to overcome drug resistance. It covers both basic research and clinical aspects of drug resistance, and involves disciplines as diverse as molecular biology, biochemistry, cell biology, pharmacology, microbiology, preclinical therapeutics, oncology and clinical medicine. Articles are written by leaders in the field, in response to an invitation from the Editors, and are peer-reviewed prior to publication. Articles are clear, readable, and up-to-date, suitable for a multidisciplinary readership and include schematic diagrams and other illustrations conveying the major points of the article. The goal is to highlight recent areas of growth and put them in perspective. *Expert reviews in clinical and basic drug resistance research in oncology and infectious disease *Describes emerging technologies and therapies, particularly those that overcome drug resistance *Emphasises common themes in microbial and cancer research

Metrics from SCImago Journal Rank 2025. View on SCImago